- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01012349
Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.
January 27, 2011 updated by: Azidus Brasil
This study aims is to evaluate, two hours after a single administration, the rate of sustained response produced by the association Geolab consisting of acetylsalicylic acid, sodium bicarbonate and anhydrous citric acid - oral powder, with the active comparator acetylsalicylic acid (Aspirin ® -- Bayer) - a simple tablet for the treatment of acute pain in patients with mild to moderate CTTE, using for both the visual analog scale pain - VAS.
Study Overview
Status
Unknown
Conditions
Detailed Description
The secondary objectives of the study are to evaluate:
- Modification of gastric pH after administration of drugs by measuring with gastroesophageal pH Monitor, comparing the results between the groups;
- The incidence of administration of rescue medications, through the accounts of patients and researchers, comparing the results between the groups;
- The percentage of improvement in time 30, 60, 90 and 120 minutes after administration, using the visual analog scale (VAS), comparing the results between the groups;
- Evaluate the gastric symptoms before and after treatment by clinical investigation of patients, comparing the results between the groups;
- Evaluate the change in associated symptoms (photophobia, phonophobia, nausea, vomiting), using 4-point scale (0 - absent 1 - mild 2 - moderate 3 - severe), comparing the results between the groups;
- Assess the quantitative and qualitative parameters related to adverse reactions, comparing the results between the groups.
Study Type
Interventional
Enrollment (Anticipated)
152
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alexandre Frederico, Physician
- Phone Number: 55 19 3829-3822
- Email: dr.alexandre@alclinica.com.br
Study Locations
-
-
SP
-
Valinhos, SP, Brazil, 13270000
- LAL Clínica Pesquisa e Desenvolvimento Ltda
-
Contact:
- Alexandre Frederico, Physician
- Phone Number: 55 19 3829-3822
- Email: dr.alexandre@alclinica.com.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Agreed to participate in the study expressed by signing the two copies of the informed consent and informed consent (IC) after approved by the IRB;
- Minimum age of 18 years;
- Clinical history of TTH, according to the criteria of the International Classification of Headache of the International Headache Society, in face of crisis.
Exclusion Criteria:
- Headache, migraine
- Chronic Tension-Type Headache (CTTH)
- Altered mental status
- Vital signs changed
- established or suspected pregnancy and lactation
- History of allergy to components of study drugs
- Current treatment with methotrexate
- Current treatment with Antinauseants
- Current treatment with anticoagulants such as heparin or coumarin-derivative
- gastric or duodenal disorders, chronic or recurrent active
- Liver and kidney disease severe
- Use of medications that have drug interactions with AAS
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test
Administration of GeoLab Association (acetylsalicylic acid, sodium bicarbonate and citric acid)
|
1 tablet in an episody of headache
|
Active Comparator: Comparator
Acetylsalicylic acid - (Aspirin - Bayer)
|
1 tablet in an episody of headache (Aspirin 500mg)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary efficacy endpoint is the rate of sustained response (percentage of subjects who have no pain) two hours after the drug administration.
Time Frame: 0, 30, 60, 90 and 120 minutes
|
0, 30, 60, 90 and 120 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
• Reduction of associated symptoms (photophobia, phonophobia, nausea, vomiting); • Symptoms stomach before and after treatment • Change in gastric pH after administration; • Incidence of administration of rescue medications; • Change in pain
Time Frame: 30, 60, 90 and 120 minutes after administration
|
30, 60, 90 and 120 minutes after administration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Anticipated)
May 1, 2011
Study Completion (Anticipated)
August 1, 2011
Study Registration Dates
First Submitted
November 12, 2009
First Submitted That Met QC Criteria
November 12, 2009
First Posted (Estimate)
November 13, 2009
Study Record Updates
Last Update Posted (Estimate)
January 28, 2011
Last Update Submitted That Met QC Criteria
January 27, 2011
Last Verified
October 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Headache Disorders, Primary
- Headache Disorders
- Headache
- Tension-Type Headache
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Fibrinolytic Agents
- Fibrin Modulating Agents
- Platelet Aggregation Inhibitors
- Cyclooxygenase Inhibitors
- Antipyretics
- Anticoagulants
- Chelating Agents
- Sequestering Agents
- Calcium Chelating Agents
- Aspirin
- Citric Acid
- Sodium Citrate
Other Study ID Numbers
- AASGEO0809
- Version 2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment of Episodic Tension Headache
-
NMP Medical Research InstituteCompleted
-
Lucia Trullenque EspallargasNot yet recruitingChronic Tension-Type Headache | Episodic Tension-Type HeadacheSpain
-
Iran University of Medical SciencesNot yet recruitingEpisodic Tension-type Headache
-
Charite University, Berlin, GermanyCassella-med GmbH & Co. KGCompleted
-
BayerCompletedHeadache | Tension-Type Headache | Tension-Type Headache (Episodic)United Kingdom
-
Poitiers University HospitalRecruitingTension-Type Headache EpisodicFrance
-
Grand Valley State UniversityMary Free Bed Rehabilitation HospitalCompletedHeadaches, TensionUnited States
-
Universidad de LeónSanidad de Castilla y LeónUnknown
-
University of ValenciaCompletedTension-type HeadacheSpain
Clinical Trials on Association: acetylsalicylic acid (500mg), sodium bicarbonate (1625) and citric acid (965)
-
Lundquist Institute for Biomedical Innovation at...Completed
-
Infante, Javier Molina, M.D.UnknownColonoscopy | Bowel CleansingSpain
-
Laboratorios Casen-Fleet S.L.U.Apices Soluciones S.L.; Trial Form Support S.L.CompletedSubjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.Spain
-
Texas Tech University Health Sciences Center, El...Withdrawn
-
Seoul National University Bundang HospitalCompleted
-
Nicola LongoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
National Cancer Center, KoreaCompletedHealthyKorea, Republic of
-
British Columbia Cancer AgencyUnknown
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Ain Shams UniversityCompletedIntrabony Periodontal Defect